> top > projects > semrep-sample > docs > PubMed:10358154 > annotations
semrep-sample Home  

PubMed:10358154 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
E1-ti-1 0-3 cui:C0205314 denotes New
E2-ti-1 22-26 cui:C0013227 denotes drug
T1 22-36 ISA denotes drug PNU156804
E3-ti-1 27-36 cui:C0768471 denotes PNU156804
E4-ti-1 44-48 cui:C0879590 denotes IL-2
E5-ti-1 59-72 cui:C0334094 denotes proliferation
E6-ti-1 77-87 cui:C0079904 denotes NF-kappa B
E7-ti-1 92-96 cui:C0002059 denotes AP-1
E1-ab-1 142-146 cui:C0013227 denotes drug
T2 142-165 ISA denotes drug undecylprodigiosin
E2-ab-1 147-165 cui:C0077826 denotes undecylprodigiosin
T3 171-177 AFFECTS denotes blocks
E3-ab-1 178-183 cui:C0020114 denotes human
T4 178-208 PROCESS_OF denotes human lymphocyte proliferation
E4-ab-1 184-208 cui:C0596873 denotes lymphocyte proliferation
E1-ab-2 248-257 cui:C0441712 denotes mechanism
E2-ab-2 273-276 cui:C0205314 denotes new
E3-ab-2 277-285 cui:C0243071 denotes analogue
E4-ab-2 289-291 cui:C0077826 denotes UP
E5-ab-2 293-302 cui:C0768471 denotes PNU156804
E6-ab-2 318-322 cui:C0205172 denotes more
E7-ab-2 323-332 cui:C0309049 denotes favorable
E8-ab-2 333-341 cui:C0439167 denotes activity
T5 350-354 compared_with denotes than
T6 350-354 higher_than denotes than
E9-ab-2 355-357 cui:C0077826 denotes UP
T7 358-360 TREATS denotes in
T8 358-360 TREATS denotes in
E10-ab-2 361-365 cui:C0026809 denotes mice
E1-ab-3 396-406 cui:C0205460 denotes biological
E2-ab-3 407-413 cui:C1280500 denotes effect
T9 407-413 INTERACTS_WITH denotes effect
E3-ab-3 417-426 cui:C0768471 denotes PNU156804
E4-ab-3 462-464 cui:C0077826 denotes UP
E5-ab-3 466-475 cui:C0768471 denotes PNU156804
E6-ab-3 483-488 cui:C0020114 denotes human
T10 483-509 PROCESS_OF denotes human T cell proliferation
E7-ab-3 489-509 cui:C1155046 denotes T cell proliferation
E8-ab-3 513-516 cui:C0444598 denotes mid
E9-ab-3 517-521 cui:C0205087 denotes late
E10-ab-3 543-553 cui:C0007586 denotes cell cycle
E11-ab-3 554-562 cui:C0936012 denotes analysis
E12-ab-3 564-574 cui:C0185117 denotes expression
E13-ab-3 578-585 cui:C0079183 denotes cyclins
E14-ab-3 591-615 cui:C0243045 denotes cyclin-dependent kinases
E15-ab-3 620-634 cui:C0035335 denotes retinoblastoma
E16-ab-3 635-650 cui:C0031715 denotes phosphorylation
E1-ab-4 655-663 cui:C0442796 denotes addition
E2-ab-4 678-687 cui:C0768471 denotes PNU156804
E3-ab-4 693-696 cui:C1518422 denotes not
E4-ab-4 721-730 cui:C0857127 denotes induction
E5-ab-4 741-745 cui:C0879590 denotes IL-2
E6-ab-4 749-754 cui:C1101536 denotes IL-2R
E7-ab-4 755-760 cui:C0439095 denotes alpha
T11 783-791 DISRUPTS denotes inhibits
E8-ab-4 792-796 cui:C0879590 denotes IL-2
E9-ab-4 807-827 cui:C1155046 denotes T cell proliferation
E1-ab-5 850-857 cui:C0443302 denotes several
E2-ab-5 858-867 cui:C1521991 denotes molecular
E3-ab-5 911-915 cui:C0879590 denotes IL-2
T12 916-918 LOCATION_OF denotes in
E4-ab-5 919-926 cui:C0039194 denotes T cells
E1-ab-6 941-950 cui:C0768471 denotes PNU156804
E2-ab-6 956-959 cui:C1518422 denotes not
T13 960-967 INHIBITS denotes inhibit
E3-ab-6 968-973 cui:C0079068 denotes c-myc
E4-ab-6 978-983 cui:C1153488 denotes bcl-2
E5-ab-6 984-988 cui:C0035696 denotes mRNA
E6-ab-6 989-998 cui:C0857127 denotes induction
E1-ab-7 1019-1028 cui:C0768471 denotes PNU156804
E2-ab-7 1072-1082 cui:C0079904 denotes NF-kappa B
E3-ab-7 1087-1091 cui:C0002059 denotes AP-1
E4-ab-7 1092-1113 cui:C0040648 denotes transcription factors
E1-ab-8 1115-1124 cui:C0768471 denotes PNU156804
E2-ab-8 1139-1149 cui:C0079904 denotes NF-kappa B
E3-ab-8 1193-1204 cui:C0243125 denotes degradation
E4-ab-8 1210-1215 cui:C0439099 denotes kappa
E5-ab-8 1218-1223 cui:C0439095 denotes alpha
E6-ab-8 1230-1235 cui:C0439099 denotes kappa
E1-ab-9 1244-1253 cui:C0768471 denotes PNU156804
E2-ab-9 1283-1301 cui:C0037080 denotes signaling pathways
E1-ab-10 1311-1314 cui:C1518422 denotes not
E2-ab-10 1322-1332 cui:C0079904 denotes NF-kappa B
T14 1333-1343 STIMULATES denotes activation
E3-ab-10 1347-1350 cui:C0048451 denotes PMA
T15 1351-1353 LOCATION_OF denotes in
E4-ab-10 1354-1361 cui:C0039194 denotes T cells
E5-ab-10 1389-1393 cui:C1367009 denotes CD40
T16 1408-1410 LOCATION_OF denotes in
E6-ab-10 1411-1424 cui:C0004561 denotes B lymphocytes
E1-ab-11 1447-1458 cui:C0033259 denotes prodigiosin
E2-ab-11 1459-1465 cui:C0015576 denotes family
E3-ab-11 1469-1487 cui:C0021081 denotes immunosuppressants
E4-ab-11 1493-1496 cui:C0205314 denotes new
E5-ab-11 1497-1503 cui:C0015576 denotes family
E6-ab-11 1507-1516 cui:C0567416 denotes molecules
E7-ab-11 1529-1534 cui:C0679622 denotes novel
E8-ab-11 1535-1541 cui:C1521840 denotes target
E9-ab-11 1542-1553 cui:C0037791 denotes specificity
E10-ab-11 1608-1613 cui:C0013227 denotes drugs
T17 1608-1635 ISA denotes drugs such as cyclosporin A
T18 1608-1635 ISA denotes drugs such as cyclosporin A
T19 1608-1635 ISA denotes drugs such as cyclosporin A
E11-ab-11 1622-1635 cui:C0010592 denotes cyclosporin A
E12-ab-11 1637-1642 cui:C0729218 denotes FK506
E13-ab-11 1648-1657 cui:C0072980 denotes rapamycin
R1 E3-ti-1 T1 subjectOf PNU156804,drug PNU156804
R10 E9-ab-2 T5 objectOf UP,than
R11 E7-ab-2 T6 subjectOf favorable,than
R12 E9-ab-2 T6 objectOf UP,than
R13 E9-ab-2 T7 subjectOf UP,in
R14 E10-ab-2 T7 objectOf mice,in
R15 E7-ab-2 T8 subjectOf favorable,in
R16 E10-ab-2 T8 objectOf mice,in
R17 E5-ab-3 T9 subjectOf PNU156804,effect
R18 E3-ab-3 T9 objectOf PNU156804,effect
R19 E7-ab-3 T10 subjectOf T cell proliferation,human T cell proliferation
R2 E2-ti-1 T1 objectOf drug,drug PNU156804
R20 E6-ab-3 T10 objectOf human,human T cell proliferation
R21 E5-ab-4 T11 subjectOf IL-2,inhibits
R22 E9-ab-4 T11 objectOf T cell proliferation,inhibits
R23 E4-ab-5 T12 subjectOf T cells,in
R24 E3-ab-5 T12 objectOf IL-2,in
R25 E1-ab-6 T13 subjectOf PNU156804,inhibit
R26 E3-ab-6 T13 objectOf c-myc,inhibit
R27 E3-ab-10 T14 subjectOf PMA,activation
R28 E2-ab-10 T14 objectOf NF-kappa B,activation
R29 E4-ab-10 T15 subjectOf T cells,in
R3 E2-ab-1 T2 subjectOf undecylprodigiosin,drug undecylprodigiosin
R30 E3-ab-10 T15 objectOf PMA,in
R31 E6-ab-10 T16 subjectOf B lymphocytes,in
R32 E5-ab-10 T16 objectOf CD40,in
R33 E11-ab-11 T17 subjectOf cyclosporin A,drugs such as cyclosporin A
R34 E10-ab-11 T17 objectOf drugs,drugs such as cyclosporin A
R35 E13-ab-11 T18 subjectOf rapamycin,drugs such as cyclosporin A
R36 E10-ab-11 T18 objectOf drugs,drugs such as cyclosporin A
R37 E12-ab-11 T19 subjectOf FK506,drugs such as cyclosporin A
R38 E10-ab-11 T19 objectOf drugs,drugs such as cyclosporin A
R4 E1-ab-1 T2 objectOf drug,drug undecylprodigiosin
R5 E2-ab-1 T3 subjectOf undecylprodigiosin,blocks
R6 E4-ab-1 T3 objectOf lymphocyte proliferation,blocks
R7 E4-ab-1 T4 subjectOf lymphocyte proliferation,human lymphocyte proliferation
R8 E3-ab-1 T4 objectOf human,human lymphocyte proliferation
R9 E7-ab-2 T5 subjectOf favorable,than